Will OpenAI or Anthropic IPO first?

**Interpretation and scope**

I interpret the market question as asking whether *at least one* of the two named companies — OpenAI or Anthropic — will complete a public offering (IPO or equivalent primary public listing) on or before 2040-01-01 UTC. This assessment excludes purely secondary liquidity events that do not create a primary public listing (e.g., only secondary market sales among private investors), but counts cross-border public listings (e.g., non‑US exchanges) and reasonably conventional direct listings or SPACs if they result in a public company.

**Stage 1 — Blind analysis (ignore current market price)**

The time horizon (≈13.5 years from today) is long relative to corporate life cycles and typical VC exit timelines. Key structural facts constrain but do not bar public listing:

- OpenAI's unique governance (capped-return model, nonprofit board influence, mission protections) complicates a standard IPO, because it would likely require organizational restructuring or creation of new share classes to satisfy public-market norms. Yet corporate governance can change: historical precedents show firms with unusual origins (e.g., Google, Meta) restructured to list when incentives aligned.

- Anthropic is VC-backed and structured more like a conventional startup; historically, VC-backed AI infrastructure/software companies have strong incentives to pursue IPOs to provide exits to backers and access capital for rapid scaling.

- Capital intensity and the competitive dynamics of frontier AI favor public access to deep capital pools if private funding becomes constrained or if growth ambitions exceed private market tolerance. Both firms are leaders in a technology area that attracts regulatory attention, partners, and customers who often prefer public-company counterparties for long-term contracts.

- Countervailing forces: national security and AI-safety regulation could restrict commercialization paths, potentially leading to long-term private status, mandated corporate structures, or forced divestitures. Further, strategic acquirers (large cloud incumbents) could buy either firm instead of letting them float.

Quantitative/heuristic reasoning: over a 13–14 year window, the historic likelihood that a top-tier late-stage private tech company either IPOs or is acquired is high. For major AI unicorns founded and scaled to global prominence by mid-2020s, the conditional probability that at least one of two such firms achieves a public listing by 2040 is well above 50%. Conditioning on: (a) Anthropic’s more conventional capital structure and (b) OpenAI’s greater structural frictions but much larger market value and strategic pressure to monetize, I assign the following component probabilities (blind to market price):

- Probability Anthropic IPOs by 2040: ~70% (could also be acquired, but IPO is a common exit for high‑growth AI firms when public markets are receptive) - Probability OpenAI IPOs by 2040: ~60% (higher operational scale and fundraising needs make listing plausible, but governance/mission friction reduces probability) - Joint correlation: these outcomes are positively correlated (if public markets favor AI leaders, both become likelier); using standard inclusion–exclusion, P(at least one) = P(A)+P(B)−P(A and B). If we assume P(A and B) ~ 0.45 given correlation, that yields ~0.85. Rounding and adding judgment about long horizon and legal/structural flexibility increases this to **88%**.

This 88% is driven by the long time horizon, capital and exit incentives, historical exit patterns for leading startups, and the strong commercial demand for frontier AI capabilities. The residual 12% accounts for scenarios where both firms are (a) acquired by large tech incumbents and integrated without a separate public listing, (b) constrained by regulatory or national-security actions that prevent a public offering, or (c) decide to remain private indefinitely via abundant private capital and robust secondary markets.

**Stage 2 — Market calibration (compare to observed market price Yes=0.80)**

The market price at 0.80 is meaningfully but not hugely below my independent 0.88. Possible reasons the market is lower:

- **Ambiguity and phrasing risk:** Traders may interpret the event narrowly (e.g., require a U.S. SEC IPO) or worry about definitions (does a direct listing, dual-class share, or SPAC count?), and that ambiguity reduces price. - **Discounting of OpenAI:** Many retail and professional traders are aware of OpenAI's unusual governance and may anchor to the view that OpenAI will *not* IPO in a conventional way, pulling the overall price down. The market may underweight Anthropic's chance or overweight acquisition risk. - **Regulatory tail risk priced more heavily by the crowd:** Market participants may place outsized weight on possible government interventions or export controls that could delay or prevent listings. - **Liquidity/participant composition:** This market has large volume but may have participants with asymmetric information or risk preferences who sell Yes exposure when they prefer not to bet on long-horizon outcomes.

Is the market mispriced? I view the market at 80% as *slightly undervaluing* the event relative to my independent assessment. The gap (8 percentage points) is within a plausible range of informational and definitional uncertainty; it is not a massive arbitrage. Traders comfortable with my assumptions could reasonably buy Yes at 0.80 expecting ~+8 points of expected value. Conversely, if you believe definitional or regulatory risks are larger than I estimate, 0.80 could be fair or even optimistic.

Trading implication: if your interpretation of the contract matches mine (counts direct listings and non‑US IPOs, counts majority of standard public listing mechanisms), I view buying Yes at 0.80 as a modestly favorable bet. If you believe the market is correctly pricing a high chance of acquisitions or government intervention, you should remain cautious.

Overall conclusion: my independent probability is 88% (Yes). The market price at 80% is slightly conservative, likely reflecting definitional ambiguity and overweighted regulatory/acquisition risks, but it is not an extreme divergence from fundamentals.